What Regulators Expect in Clinical Trial Conduct
- 0:00 Why Conduct Gets Scrutinized
- 8:00 Who Owns What
- 18:00 Protocol Compliance In Practice
Practical shifts you can apply this week
-
Identify Regulatory Conduct Principles
Spot how inspectors judge rights, safety, and data integrity when the paperwork looks fine but the system does not.
-
Compare Regulator Expectations Across Functions
See where oversight, documentation, deviations, and safety management align and where teams often drift apart.
-
Diagnose Common Trial Conduct Failures
Recognize the repeat patterns that turn small misses into audit findings, warning letters, or awkward follow-up calls.
-
Apply A Risk-Based Approach
Make clearer calls on CAPA, escalation, and oversight using risk signals that actually lead to action.
-
Draft Practical Inspection Readiness Actions
Leave with a simple way to turn gaps in active studies into owner-assigned next steps and usable evidence.
What we'll cover
-
0:00
Why Conduct Gets Scrutinized
Start with the regulator's lens: participant protection, credible data, and why tidy files do not guarantee compliant conduct.
-
8:00
Who Owns What
Sponsor and investigator accountability, vendor oversight, delegation, and what active supervision looks like in practice.
-
18:00
Protocol Compliance In Practice
How deviations are prevented, detected, classified, and addressed before they become repeat patterns.
-
28:00
Documentation That Holds Up
ALCOA+, audit trails, source and TMF alignment, and why late reconstruction rarely ages well.
-
37:00
Safety Signals And Escalation
AE and SAE flow, medical review, escalation paths, and when delays create real regulatory concern.
-
46:00
Risk-Based Oversight And CAPA
Use KRIs, triggered review, and remediation checks to show that oversight decisions lead somewhere concrete.
-
54:00
Red Flags, Recap, Q&A
Inspection triggers, credible responses, a 30-day action plan prompt, and live audience questions.
Questions people ask before registering
-
It is built for working professionals involved in trial conduct and oversight, including clinical operations, quality, safety, and study leadership roles. If you influence how a study is run or documented, it will be relevant.
-
No. The session assumes you know the basics of clinical trials, then shows how regulators apply those basics in real oversight decisions. Examples are practical, not academic.
-
Most webinar programs provide a replay to registered attendees after the live session. Check your registration details for the specific access window and timing.
-
Both. The session covers sponsor, CRO, vendor, and investigator responsibilities because regulators follow the chain of accountability across the full study system.
-
Certificate availability depends on the webinar host's process. If certificates are offered, they are typically sent after attendance is confirmed.
-
It is grounded in practical examples, including oversight failures, delayed safety escalation, and documentation gaps that looked acceptable until someone tried to reconstruct what happened.